Wealth Enhancement Advisory Services
PAHC icon

Wealth Enhancement Advisory Services’s Phibro Animal Health PAHC Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,629
Closed -$201K – 4205
2026
Q1 		$201K Sell
3,629
-1,890
-34% -$90K ﹤0.01% 3129
2025
Q4 		$218K Buy
+5,519
New +$224K ﹤0.01% 3202

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wealth Enhancement Advisory Services's PAHC Position: Q2 2026 in Review

Wealth Enhancement Advisory Services sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 3,629 shares — an estimated $201K sold.

Wealth Enhancement Advisory Services first reported a position in PAHC in Q4 2025 and held it in 2 quarters. The position peaked at $218K in Q4 2025. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Wealth Enhancement Advisory Services reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 3,629 Phibro Animal Health shares in Q2 2026, an estimated $201K.
  • Wealth Enhancement Advisory Services first reported a position in Phibro Animal Health in Q4 2025 and held it in 2 quarters.
  • Wealth Enhancement Advisory Services's Phibro Animal Health position peaked at $218K in Q4 2025.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.